New four-in-one flu shot may provide protection from all influenza viruses

The study is the first to report on whether a universal flu shot could be created by using a combination of multiple genes shared at the ancestral level

Image
Press Trust of India Washington
Last Updated : Nov 03 2017 | 1:35 PM IST
A vaccine combining ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, a study conducted on mice has found.

Mice protected by the unconventional vaccine survived exposure to lethal doses of seven of nine widely divergent influenza viruses, according to researchers from the University of Nebraska-Lincoln in the US.

Those that received higher doses of the vaccine did not even get sick. In contrast, mice that received traditional flu shots or nasal sprays all sickened and died when exposed to the same viruses.

Also Read

The deadly pathogens were able to evade the immune responses triggered by the traditional vaccines, researchers found.

While it is too soon to say the approach could be successfully used in humans, it appears to be a promising avenue towards a universal flu shot, said Eric Weaver, an assistant professor at the University of Nebraska-Lincoln.

The study is the first to report on whether a universal flu shot could be created by using a combination of multiple genes shared at the ancestral level by flu strains circulating today, he said.

"The ultimate goal is to be able to vaccinate once and provide lifelong protection," said Weaver, who led the study published in the journal Scientific Reports.

The conventional influenza vaccine platform uses weakened or dead versions of the influenza virus to stimulate immunity against hemagglutinin (HA), a spike-shaped protein that extends from the surface of the virus and attacks cells.

Conventional vaccines have been shown to be less than 60 per cent effective when they are successfully matched to the currently circulating strain. They are far less effective when mismatched, researchers said.

"An ideal influenza vaccine would be inexpensive, provide long-lasting immunity, require few immunisations and would work against all variants of the virus," Weaver said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 03 2017 | 12:28 PM IST

Next Story